Leyden Labs
John Cassidy is an accomplished Investment Director at SoftBank Investment Advisers, specializing in Life Sciences and HealthTech since 2021. With experience as a board member for companies such as Neuron23, CMR Surgical, Ventus Therapeutics, Big Health, and Leyden Labs, John Cassidy actively contributes to the growth of innovative health enterprises. Prior roles include serving as a board member for Twelve Bio and Stipe Therapeutics, the latter transitioning from Board Observer to Board Director. John Cassidy holds a Doctor of Philosophy (PhD) in Neuroscience from UCL and a Bachelor of Science in Biochemistry from Imperial College London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Leyden Labs
2 followers
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.